From: Cellular immunotherapy as maintenance therapy prolongs the survival of the patients with small cell lung cancer
Immune cells
Before (median, range)
After (median, range)
NK cells
8.01 % (4.12–17.35 %)
85.32 % (61.33–99.61 %)
γδT cells
4.22 % (2.79–11.26 %)
82.63 % (63.72–98.21 %)
CIK cells
4.51 % (1.62–7.96 %)
34.52 % (27.25–57.28 %)